Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

665 ARTÍCULOS , VIENDO DEL 346 AL 360

Current Anti-Amyloid-β Therapy for Alzheimer's Disease Treatment: From Clinical Research to Nanomedicine

Zhao Z, Liu Y, Ruan S, Hu Y.

Int J Nanomedicine. 2023 Dec 20;18:7825-7845. doi: 10.2147/IJN.S444115. eCollection 2023.

[Russian experience in using a combination of fixed doses of donepezil and memantine in the treatment of Alzheimer's disease as an observational non-interventional multicenter program]

Kolykhalov IV, Mkhitaryan EA, Fedorova YB, Ponomareva EV, Selezneva ND, Cherdak MA, Dudchenko NG, Seyfedinova AB, Isaev RI, Gavrilova SI, Tkacheva ON.

Zh Nevrol Psikhiatr Im S S Korsakova. 2023;123(12):69-75. doi: 10.17116/jnevro202312312169.

Drug Repositioning of Pioglitazone in Management and Improving the Cognitive Function among the Patients With Mild to Moderate Alzheimer's Disease: A Systematic Review and Meta-Analysis

Basutkar RS, Sudarsan P, Robin SM, Bhaskar V, Viswanathan B, Sivasankaran P.

Neurol India. 2023 Nov-Dec;71(6):1132-1141. doi: 10.4103/0028-3886.391397.

Switching On/Off Amyloid Plaque Formation in Transgenic Animal Models of Alzheimer's Disease

Kozin SA, Kechko OI, Adzhubei AA, Makarov AA, Mitkevich VA.

Int J Mol Sci. 2023 Dec 20;25(1):72. doi: 10.3390/ijms25010072.

Mechanisms of 3-Hydroxyl 3-Methylglutaryl CoA Reductase in Alzheimer's Disease

Zhou X, Wu X, Wang R, Han L, Li H, Zhao W.

Int J Mol Sci. 2023 Dec 22;25(1):170. doi: 10.3390/ijms25010170.

Systematic review and meta‑analysis of observational studies to check the protective role of non‑steroidal anti‑inflammatory drugs in Alzheimer's disease

Asthana A, Tripathi S, Agarwal R.

Acta Neurobiol Exp (Wars). 2023 Dec 4;83(4):386-394. doi: 10.55782/ane-2023-2467.

Androgen Deprivation Therapy for Prostate Cancer: Focus on Cognitive Function and Mood

Reiss AB, Gulkarov S, Pinkhasov A, Sheehan KM, Srivastava A, De Leon J, Katz AE.

Medicina (Kaunas). 2023 Dec 30;60(1):77. doi: 10.3390/medicina60010077.

Interactions of Polyphenolic Gallotannins with Amyloidogenic Polypeptides Associated with Alzheimer's Disease: From Molecular Insights to Physiological Significance

Khalifa J, Bourgault S, Gaudreault R.

Curr Alzheimer Res. 2023;20(9):603-617. doi: 10.2174/0115672050277001231213073043.

The Potential of a Stratified Approach to Drug Repurposing in Alzheimer's Disease

Anderson C, Bucholc M, McClean PL, Zhang SD.

Biomolecules. 2023 Dec 21;14(1):11. doi: 10.3390/biom14010011.

Serotonin Receptors as a Potential Target in the Treatment of Alzheimer's Disease

Eremin DV, Kondaurova EM, Rodnyy AY, Molobekova CA, Kudlay DA, Naumenko VS.

Biochemistry (Mosc). 2023 Dec;88(12):2023-2042. doi: 10.1134/S0006297923120064.

Androgen Deprivation Therapy Unrelated to Alzheimer's Disease in the UK Biobank Cohort

Lehrer S, Rheinstein PH.

Anticancer Res. 2023 Jan;43(1):437-440. doi: 10.21873/anticanres.16179.

Recent Trends in Nano-Particulate Carriers for the Diagnosis and Treatment of Alzheimer's Disease

Mazahir F, Yadav AK.

CNS Neurol Disord Drug Targets. 2023;22(4):477-499. doi: 10.2174/1871527321666220420133059.

Extravaganza of Nanobiotechnology in the Diagnosis and Treatment of Dementia Patients

Bhattacharya S.

Curr Pharm Biotechnol. 2023;24(9):1108-1121. doi: 10.2174/1385272827666221027103050.

Characterization of exposure-Clinical Dementia Rating-Sum of Boxes relationship in subjects with early Alzheimer's disease from the aducanumab Phase 3 trials

Muralidharan KK, Kowalski KG, Tong X, Haeberlein SB, Rajagovindan R, Nestorov I.

J Pharmacokinet Pharmacodyn. 2023 Feb;50(1):45-62. doi: 10.1007/s10928-022-09839-3. Epub 2023 Jan 4.

A Review of Scientific Ethics Issues Associated with the Recently Approved Drugs for Alzheimer's Disease

Yeo-Teh NSL, Tang BL.

Sci Eng Ethics. 2023 Jan 10;29(1):2. doi: 10.1007/s11948-022-00422-0.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias